{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where agency_id = \"FDA\" and docket_id = \"FDA-2014-N-1210\" sorted by posted_date descending", "rows": [["FDA-2014-N-1210-3494", "FDA", "FDA-2014-N-1210", "Reference 58-Brown E.D. et al. Efficacy of continuation-maintenance electroconvulsive therapy for the prevention of recurrence of a major depressi  RE:  Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-06T05:00:00Z", 2019, 3, null, null, "2019-03-06T15:33:14Z", null, 0, 0, "0900006483ac3808"], ["FDA-2014-N-1210-3493", "FDA", "FDA-2014-N-1210", "Reference 23-Shelef A. et al. Acute electroconvulsive therapy followed by maintenance electroconvulsive therapy decreases hospital re-admission ra  RE:  Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-06T05:00:00Z", 2019, 3, null, null, "2019-03-06T15:33:05Z", null, 0, 0, "0900006483ac3807"], ["FDA-2014-N-1210-3449", "FDA", "FDA-2014-N-1210", "Reference 18-Luchini, F., et al., Electroconvulsive therapy in catatonic patients- Efficacy and predictors of response  Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T20:59:45Z", null, 0, 0, "0900006483876153"], ["FDA-2014-N-1210-3434", "FDA", "FDA-2014-N-1210", "Reference 2-Reclassification of Daily Wear Spherical Contact Lenses Consisting of Rigid Gas Permeable Plastic Materials; Withdrawal of Proposed Rule FR-1983-12-23  Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T20:57:24Z", null, 0, 0, "0900006483875dfa"], ["FDA-2014-N-1210-3436", "FDA", "FDA-2014-N-1210", "Reference 4 - FDA Executive Summary, Prepared for the January 27-28, 2011 meeting of the Neurological Devices Panel, Meeting to Discuss the Classification  Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T20:57:41Z", null, 0, 0, "0900006483875dfc"], ["FDA-2014-N-1210-3477", "FDA", "FDA-2014-N-1210", "Reference 47-Petrides, G., et al., Electroconvulsive therapy augmentation in clozapine-resistant schizophrenia- a prospective, randomized study Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T21:03:49Z", null, 0, 0, "0900006483875ea0"], ["FDA-2014-N-1210-3478", "FDA", "FDA-2014-N-1210", "Reference 48-Lehman, A.F., et al., Practice guideline for the treatment of patients with schizophrenia, second edition Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T21:03:58Z", null, 0, 0, "0900006483875ea1"], ["FDA-2014-N-1210-3481", "FDA", "FDA-2014-N-1210", "Reference 51-Small, J.G., et al., Electroconvulsive treatment compared with lithium in the management of manic states Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T21:04:24Z", null, 0, 0, "0900006483875ef1"], ["FDA-2014-N-1210-3459", "FDA", "FDA-2014-N-1210", "Reference 29-Puffer, C.C., et al., A 20 Year Practice Review of Electroconvulsive Therapy for Adolescents  Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T21:01:03Z", null, 0, 0, "0900006483876176"], ["FDA-2014-N-1210-3463", "FDA", "FDA-2014-N-1210", "Reference 33-Consoli, A., et al., Electroconvulsive therapy in adolescents with the catatonia syndrome- efficacy and ethics  Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T21:01:38Z", null, 0, 0, "090000648387617b"], ["FDA-2014-N-1210-3455", "FDA", "FDA-2014-N-1210", "Reference 25-Unal, A., et al., Effective treatment of catatonia by combination of benzodiazepine and electroconvulsive therapy  Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T21:00:31Z", null, 0, 0, "0900006483875e58"], ["FDA-2014-N-1210-3454", "FDA", "FDA-2014-N-1210", "Reference 24-Sienaert, P., et al., A clinical review of the treatment of catatonia  Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T21:00:23Z", null, 0, 0, "0900006483875e56"], ["FDA-2014-N-1210-3437", "FDA", "FDA-2014-N-1210", "Reference 5-Fernie, G., et al., Detecting objective and subjective cognitive effects of electroconvulsive therapy- intensity, duration and test utility in a large clinical sample  Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T20:57:53Z", null, 0, 0, "0900006483875dfd"], ["FDA-2014-N-1210-3489", "FDA", "FDA-2014-N-1210", "Reference 60-Tor, P.C., et al., A Systematic Review and Meta-Analysis of Brief Versus Ultrabrief Right Unilateral Electroconvulsive Therapy for Depression Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T21:05:34Z", null, 0, 0, "09000064838a4653"], ["FDA-2014-N-1210-3458", "FDA", "FDA-2014-N-1210", "Reference 28-Lima, N.N., et al., Electroconvulsive therapy use in adolescents- a systematic review  Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T21:00:53Z", null, 0, 0, "0900006483876175"], ["FDA-2014-N-1210-3465", "FDA", "FDA-2014-N-1210", "Reference 35-Walter, G. and J.M. Rey, An epidemiological study of the use of ECT in adolescents  Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T21:01:53Z", null, 0, 0, "090000648387617d"], ["FDA-2014-N-1210-3439", "FDA", "FDA-2014-N-1210", "Reference 7-Maric, N.P., et al., The acute and medium-term effects of treatment with electroconvulsive therapy on memory in patients with major depressive disorder  Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T20:58:08Z", null, 0, 0, "0900006483875e0f"], ["FDA-2014-N-1210-3442", "FDA", "FDA-2014-N-1210", "Reference 10-Ghaziuddin, N., D. Laughrin, and B. Giordani, Cognitive side effects of electroconvulsive therapy in adolescents  Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T20:58:38Z", null, 0, 0, "0900006483875e12"], ["FDA-2014-N-1210-3467", "FDA", "FDA-2014-N-1210", "Reference 37-Strober, M., et al., Effects of electroconvulsive therapy in adolescents with severe endogenous depression resistant to pharmacotherapy  Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T21:02:26Z", null, 0, 0, "0900006483875e81"], ["FDA-2014-N-1210-3486", "FDA", "FDA-2014-N-1210", "Reference 56-FDA, MedWatch- The FDA Safety Information and Adverse Event Reporting Program Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T21:05:04Z", null, 0, 0, "09000064838a4650"], ["FDA-2014-N-1210-3453", "FDA", "FDA-2014-N-1210", "Reference 22-Raveendranathan, D., J.C. Narayanaswamy, and S.V. Reddi, Response rate of catatonia to electroconvulsive therapy and its clinical correlates  Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T21:00:17Z", null, 0, 0, "0900006483875e55"], ["FDA-2014-N-1210-3451", "FDA", "FDA-2014-N-1210", "Reference 20-Medda, P., et al., Electroconvulsive therapy in 197 patients with a severe, drug-resistant bipolar mixed state- treatment outcome and predictors of response  Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T20:59:59Z", null, 0, 0, "0900006483875e51"], ["FDA-2014-N-1210-3433", "FDA", "FDA-2014-N-1210", "Reference 1- Medical Device Accessories - Describing Accessories and Classification Pathways - Guidance for Industry and FDA Staff Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T20:57:13Z", null, 0, 0, "0900006483875df9"], ["FDA-2014-N-1210-3452", "FDA", "FDA-2014-N-1210", "Reference 21-Raffin, M., et al., Treatment use in a prospective naturalistic cohort of children and adolescents with catatonia  Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T21:00:09Z", null, 0, 0, "0900006483875e54"], ["FDA-2014-N-1210-3471", "FDA", "FDA-2014-N-1210", "Reference 41-Panel Transcript Jan 27-28 2011 Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T21:02:59Z", null, 0, 0, "0900006483875e86"], ["FDA-2014-N-1210-3492", "FDA", "FDA-2014-N-1210", "Reference 17-Jacob, P., et al., Review of electroconvulsive therapy practice from a tertiary Child and Adolescent Psychiatry Centre  Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T21:23:47Z", null, 0, 0, "0900006483876152"], ["FDA-2014-N-1210-3461", "FDA", "FDA-2014-N-1210", "Reference 31-Zhang, Z.J., et al., Electroconvulsive therapy improves antipsychotic and somnographic responses in adolescents with first-episode psychosis--a case-control study  Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T21:01:18Z", null, 0, 0, "0900006483876179"], ["FDA-2014-N-1210-3450", "FDA", "FDA-2014-N-1210", "Reference 19-Medda, P., et al., Catatonia in 26 patients with bipolar disorder- clinical features and response to electroconvulsive therapy  Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T20:59:51Z", null, 0, 0, "0900006483876154"], ["FDA-2014-N-1210-3488", "FDA", "FDA-2014-N-1210", "Reference 59-de Sousa, R.T., et al., Challenging Treatment-Resistant Major Depressive Disorder- A Roadmap for Improved Therapeutics Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T21:05:23Z", null, 0, 0, "09000064838a4652"], ["FDA-2014-N-1210-3443", "FDA", "FDA-2014-N-1210", "Reference 11-Dessens, F.M., et al., Electroconvulsive therapy in the intensive care unit for the treatment of catatonia-a case series and review of the literature  Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T20:58:46Z", null, 0, 0, "0900006483875e14"], ["FDA-2014-N-1210-3457", "FDA", "FDA-2014-N-1210", "Reference 27-Ghaziuddin, N., S. Dumas, and E. Hodges, Use of continuation or maintenance electroconvulsive therapy in adolescents with severe treatment-resistant depression  Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T21:00:46Z", null, 0, 0, "0900006483875e5a"], ["FDA-2014-N-1210-3460", "FDA", "FDA-2014-N-1210", "Reference 30-de la Serna, E., et al., Two-year follow-up of cognitive functions in schizophrenia spectrum disorders of adolescent patients treated with electroconvulsive therapy  Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T21:01:12Z", null, 0, 0, "0900006483876177"], ["FDA-2014-N-1210-3470", "FDA", "FDA-2014-N-1210", "Reference 40-Ghaziuddin, N., et al., Practice parameter for use of electroconvulsive therapy with adolescents re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T21:02:49Z", null, 0, 0, "0900006483875e84"], ["FDA-2014-N-1210-3483", "FDA", "FDA-2014-N-1210", "Reference 53-  Interim report of the Special Rapporteur on torture and other cruel, inhuman or degrading treatment or punishment UN Report Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T21:04:42Z", null, 0, 0, "0900006483875ef3"], ["FDA-2014-N-1210-3440", "FDA", "FDA-2014-N-1210", "Reference 8-Spaans, H.P., et al., Efficacy and cognitive side effects after brief pulse and ultrabrief pulse right unilateral electroconvulsive therapy for major depression  Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T20:58:19Z", null, 0, 0, "0900006483875e10"], ["FDA-2014-N-1210-3482", "FDA", "FDA-2014-N-1210", "Reference 52-Milstein, V., et al., Does Electroconvulsive Therapy Prevent Suicide Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T21:04:34Z", null, 0, 0, "0900006483875ef2"], ["FDA-2014-N-1210-3474", "FDA", "FDA-2014-N-1210", "Reference 44-Iancu, I., et al., Patients with schizophrenia or schizoaffective disorder who receive multiple electroconvulsive therapy sessions- characteristics, indications, and results Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T21:03:25Z", null, 0, 0, "0900006483875e89"], ["FDA-2014-N-1210-3479", "FDA", "FDA-2014-N-1210", "Reference 49-Black, D.W., G. Winokur, and A. Nasrallah, ECT in Unipolar and Bipolar Disorders- A Naturalistic Evaluation of 460 Patients Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T21:04:06Z", null, 0, 0, "0900006483875ea7"], ["FDA-2014-N-1210-3485", "FDA", "FDA-2014-N-1210", "Reference 55-Texas Dept. of State Health Services Electroconvulsive Therapy (ECT) Reports Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T21:04:57Z", null, 0, 0, "09000064838a464f"], ["FDA-2014-N-1210-3438", "FDA", "FDA-2014-N-1210", "Reference 6-Kirov, G.G., et al., Evaluation of cumulative cognitive deficits from electroconvulsive therapy.  Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T20:58:00Z", null, 0, 0, "0900006483875e01"], ["FDA-2014-N-1210-3472", "FDA", "FDA-2014-N-1210", "Reference 42-Baeza, I., et al., Clinical experience using electroconvulsive therapy in adolescents with schizophrenia spectrum disorders Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T21:03:08Z", null, 0, 0, "0900006483875e87"], ["FDA-2014-N-1210-3462", "FDA", "FDA-2014-N-1210", "Reference 32-Cohen, D., et al., Absence of cognitive impairment at long-term follow-up in adolescents treated with ECT for severe mood disorder  Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T21:01:26Z", null, 0, 0, "090000648387617a"], ["FDA-2014-N-1210-3432", "FDA", "FDA-2014-N-1210", "REFERENCES LIST  RE:  Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T20:56:54Z", null, 0, 0, "0900006483875df8"], ["FDA-2014-N-1210-3491", "FDA", "FDA-2014-N-1210", "Reference 62-Device Labeling Guidance No. G91-1 Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T21:05:50Z", null, 0, 0, "09000064838a4655"], ["FDA-2014-N-1210-3444", "FDA", "FDA-2014-N-1210", "Reference 12-England, M.L., et al., Catatonia in psychotic patients- clinical features and treatment response   Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T20:58:57Z", null, 0, 0, "0900006483875e15"], ["FDA-2014-N-1210-3441", "FDA", "FDA-2014-N-1210", "Reference 9-Semkovska, M., et al., Bitemporal Versus High-Dose Unilateral Twice-Weekly Electroconvulsive Therapy for Depression (EFFECT-Dep)  Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T20:58:30Z", null, 0, 0, "0900006483875e11"], ["FDA-2014-N-1210-3469", "FDA", "FDA-2014-N-1210", "Reference 39-Kutcher, S.R., HA. , Electroconvulsive therapy in treatment-resistant bipolar youth re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T21:02:42Z", null, 0, 0, "0900006483875e83"], ["FDA-2014-N-1210-3487", "FDA", "FDA-2014-N-1210", "Reference 57-Neurological Devices Panel ECT - Janu 2011 24 Hour Summary Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T21:05:13Z", null, 0, 0, "09000064838a4651"], ["FDA-2014-N-1210-3447", "FDA", "FDA-2014-N-1210", "Referrence 15-Ghaziuddin, N., D. Dhossche, and K. Marcotte, Retrospective chart review of catatonia in child and adolescent psychiatric patients  Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T20:59:24Z", null, 0, 0, "0900006483875e18"], ["FDA-2014-N-1210-3446", "FDA", "FDA-2014-N-1210", "Reference 14-Flamarique, I., et al., Long-term effectiveness of electroconvulsive therapy in adolescents with schizophrenia spectrum disorders  Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T20:59:13Z", null, 0, 0, "0900006483875e17"], ["FDA-2014-N-1210-3464", "FDA", "FDA-2014-N-1210", "Reference 34-Rey, J.M. and G. Walter, Half a century of ECT use in young people  Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T21:01:46Z", null, 0, 0, "090000648387617c"], ["FDA-2014-N-1210-3456", "FDA", "FDA-2014-N-1210", "Reference 26-Hasan, A., et al., World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1  Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T21:00:38Z", null, 0, 0, "0900006483875e59"], ["FDA-2014-N-1210-3445", "FDA", "FDA-2014-N-1210", "Reference 13-Faedda, G.L., et al., Catatonia in an adolescent with velo-cardio-facial syndrome  Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T20:59:05Z", null, 0, 0, "0900006483875e16"], ["FDA-2014-N-1210-3435", "FDA", "FDA-2014-N-1210", "Reference 3-Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices - Guidance for Industry and Food and Drug Administration Staff  Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T20:57:31Z", null, 0, 0, "0900006483875dfb"], ["FDA-2014-N-1210-3490", "FDA", "FDA-2014-N-1210", "Reference 61-Diagnostic and Statistical Manual of Mental Disorders Fifth Edition DSM-5 Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T21:05:42Z", null, 0, 0, "09000064838a4654"], ["FDA-2014-N-1210-3480", "FDA", "FDA-2014-N-1210", "Reference 50-Mukherjee, S. and V. Debsikdar, Unmodified Electroconvulsive Therapy of Acute Mania- A Retrospective Naturalistic Study Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T21:04:15Z", null, 0, 0, "0900006483875ea8"], ["FDA-2014-N-1210-3468", "FDA", "FDA-2014-N-1210", "Reference 38-Cohen, D., M.L. Paillere-Martinot, and M. Basquin, Use of electroconvulsive therapy in adolescents  Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T21:02:34Z", null, 0, 0, "0900006483875e82"], ["FDA-2014-N-1210-3475", "FDA", "FDA-2014-N-1210", "Reference 45-Kristensen, D., et al., Electroconvulsive therapy for treating schizophrenia- a chart review of patients from two catchment areas Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T21:03:33Z", null, 0, 0, "0900006483875e8a"], ["FDA-2014-N-1210-3466", "FDA", "FDA-2014-N-1210", "Reference 36-Ghaziuddin, N., et al., Electroconvulsive treatment in adolescents with pharmacotherapy-refractory depression  Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T21:02:01Z", null, 0, 0, "090000648387617e"], ["FDA-2014-N-1210-3473", "FDA", "FDA-2014-N-1210", "Reference 43-Benzoni, O.e.a., Treatment of resistant mood and schizoaffective disorders with electroconvulsive therapy Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T21:03:17Z", null, 0, 0, "0900006483875e88"], ["FDA-2014-N-1210-3448", "FDA", "FDA-2014-N-1210", "Reference 16-Haq, A.U. and N. Ghaziuddin, Maintenance electroconvulsive therapy for aggression and self-injurious behavior in two adolescents with autism and catatonia  Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T20:59:31Z", null, 0, 0, "0900006483876151"], ["FDA-2014-N-1210-3476", "FDA", "FDA-2014-N-1210", "Reference 46-Levy-Rueff, M., et al., Maintenance electroconvulsive therapy- an alternative treatment for refractory schizophrenia and schizoaffective disorders Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T21:03:40Z", null, 0, 0, "0900006483875e9f"], ["FDA-2014-N-1210-3484", "FDA", "FDA-2014-N-1210", "Reference 54 - Mental Health - A Report of the Surgeon General Re: Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Supporting & Related Material", "Background Material", "2019-03-05T05:00:00Z", 2019, 3, null, null, "2019-03-05T21:04:49Z", null, 0, 0, "0900006483875ef5"], ["FDA-2014-N-1210-3431", "FDA", "FDA-2014-N-1210", "Neurological Devices; Reclassification of Electroconvulsive Therapy Devices; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy Devices for Certain Specified Intended Uses", "Rule", "Final Rule", "2018-12-26T05:00:00Z", 2018, 12, "2018-12-26T05:00:00Z", null, "2019-01-10T02:12:36Z", "2018-27809", 0, 0, "09000064839c4d26"], ["FDA-2014-N-1210-0003", "FDA", "FDA-2014-N-1210", "Reference 1 - The Practice of Electroconvulsive Therapy - Recommendations for Treatment, Training and Privileging", "Supporting & Related Material", "Reference (external attachments)", "2015-12-29T05:00:00Z", 2015, 12, null, null, "2015-12-29T17:24:31Z", null, 0, 0, "0900006481dd8bf6"], ["FDA-2014-N-1210-0009", "FDA", "FDA-2014-N-1210", "Reference 7 - Antidepressant Drug Effects and Depression Severity: A Patient-Level Meta-Analysis", "Supporting & Related Material", "Reference (external attachments)", "2015-12-29T05:00:00Z", 2015, 12, null, null, "2015-12-29T17:23:16Z", null, 0, 0, "0900006481dd8c8e"], ["FDA-2014-N-1210-0011", "FDA", "FDA-2014-N-1210", "Reference 9 - An Examination of Mortality and Other Adverse Events Related to Electroconvulsive Therapy Using a National Adverse Event Report System", "Supporting & Related Material", "Reference (external attachments)", "2015-12-29T05:00:00Z", 2015, 12, null, null, "2015-12-29T17:22:54Z", null, 0, 0, "0900006481dd8e03"], ["FDA-2014-N-1210-0006", "FDA", "FDA-2014-N-1210", "Reference 4 - Mental Health - A Report of the Surgeon General", "Supporting & Related Material", "Reference (external attachments)", "2015-12-29T05:00:00Z", 2015, 12, null, null, "2015-12-29T17:23:50Z", null, 0, 0, "0900006481dd8c8b"], ["FDA-2014-N-1210-0004", "FDA", "FDA-2014-N-1210", "Reference 2 - Guidance on the Use of Electroconvulsive Therapy", "Supporting & Related Material", "Reference (external attachments)", "2015-12-29T05:00:00Z", 2015, 12, null, null, "2015-12-29T17:24:16Z", null, 0, 0, "0900006481dd8bfa"], ["FDA-2014-N-1210-0008", "FDA", "FDA-2014-N-1210", "Reference 6 - Clinical and Cost-Effectiveness of Electroconvulsive Therapy for Depressive Illness, Schizophrenia, Catatonia and Mania-Systematic Reviews and Economic Modelling Studies", "Supporting & Related Material", "Reference (external attachments)", "2015-12-29T05:00:00Z", 2015, 12, null, null, "2015-12-29T17:23:27Z", null, 0, 0, "0900006481dd8c8d"], ["FDA-2014-N-1210-0007", "FDA", "FDA-2014-N-1210", "Reference 5 - Objective Cognitive Performance Associated with Electroconvulsive Therapy for Depression- A Systematic Review and Meta-Analysis", "Supporting & Related Material", "Reference (external attachments)", "2015-12-29T05:00:00Z", 2015, 12, null, null, "2015-12-29T17:23:38Z", null, 0, 0, "0900006481dd8c8c"], ["FDA-2014-N-1210-0010", "FDA", "FDA-2014-N-1210", "Reference 8 - Initial Severity and Antidepressant Benefits- A Meta-Analysis of Data Submitted to the Food and Drug Administration", "Supporting & Related Material", "Reference (external attachments)", "2015-12-29T05:00:00Z", 2015, 12, null, null, "2015-12-29T17:23:04Z", null, 0, 0, "0900006481dd8e02"], ["FDA-2014-N-1210-0002", "FDA", "FDA-2014-N-1210", "List of References for Reclassification of Electroconvulsive Therapy (ECT) Devices Intended for Use in Treating Severe Major Depressive Episode in Patients 18 Years of Age and Older Who are Treatment Resistant or Require a Rapid Response; Effective Date of Requirement for Premarket Approval for ECT Devices for Certain Specified Intended Uses Proposed Order", "Supporting & Related Material", "List", "2015-12-29T05:00:00Z", 2015, 12, null, null, "2015-12-29T17:24:43Z", null, 0, 0, "0900006481dd8bf5"], ["FDA-2014-N-1210-0005", "FDA", "FDA-2014-N-1210", "Reference 3 - Depression in Adults - The Treatment and Management of Depression in Adults", "Supporting & Related Material", "Reference (external attachments)", "2015-12-29T05:00:00Z", 2015, 12, null, null, "2015-12-29T17:24:01Z", null, 0, 0, "0900006481dd8bfb"], ["FDA-2014-N-1210-0001", "FDA", "FDA-2014-N-1210", "Neurological Devices; Reclassification of Electroconvulsive Therapy Devices Intended for Use in Treating Severe Major Depressive Episode in Patients 18 Years of Age and Older Who Are Treatment Resistant or Require a Rapid Response; Effective Date of Requirement for Premarket Approval for Electroconvulsive Therapy for Certain Specified Intended Uses", "Proposed Rule", "Notice of Proposed Rulemaking (NPRM)", "2015-12-29T05:00:00Z", 2015, 12, "2015-12-29T05:00:00Z", "2016-03-29T03:59:59Z", "2019-01-14T20:50:27Z", "2015-32592", 0, 0, "0900006481dd79bf"], ["FDA-2014-N-1210-0012", "FDA", "FDA-2014-N-1210", "Reference 10 - Electroconvulsive Therapy in Lorazepam Non-Responsive Catatonia", "Supporting & Related Material", "Reference (external attachments)", "2015-12-29T05:00:00Z", 2015, 12, null, null, "2015-12-29T17:22:43Z", null, 0, 0, "0900006481dd8e0a"], ["FDA-2014-N-1210-0013", "FDA", "FDA-2014-N-1210", "Reference 11 - FDA Executive Summary - Prepared for the March 17, 2011 Meeting of the Neurologic Devices Panel", "Supporting & Related Material", "Reference (internal unless indicated)", "2015-12-29T05:00:00Z", 2015, 12, null, null, "2015-12-29T17:22:32Z", null, 0, 0, "0900006481dd8e0b"]], "truncated": false, "filtered_table_rows_count": 77, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"agency_id\" = :p0 and \"docket_id\" = :p1 order by posted_date desc limit 101", "params": {"p0": "FDA", "p1": "FDA-2014-N-1210"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-N-1210", "results": [{"value": "FDA", "label": "FDA", "count": 77, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2014-N-1210", "selected": true}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-N-1210", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 75, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-N-1210&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Proposed Rule", "label": "Proposed Rule", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-N-1210&document_type=Proposed+Rule", "selected": false}, {"value": "Rule", "label": "Rule", "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-N-1210&document_type=Rule", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-N-1210", "results": [{"value": 2019, "label": 2019, "count": 63, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-N-1210&posted_year=2019", "selected": false}, {"value": 2015, "label": 2015, "count": 13, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-N-1210&posted_year=2015", "selected": false}, {"value": 2018, "label": 2018, "count": 1, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-N-1210&posted_year=2018", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-N-1210&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-N-1210&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-N-1210&_facet=posted_month"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-N-1210&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-N-1210&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-N-1210&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?agency_id=FDA&docket_id=FDA-2014-N-1210&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 1111.6237960522994, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}